H-1B sponsorship profile: Ascendia Pharmaceuticals, Inc. Across U.S. Department of Labor LCA disclosures, Ascendia Pharmaceuticals, Inc filed 9 Labor Condition Applications covering 9 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (9 certified of 9 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Ascendia Pharmaceuticals, Inc’s H-1B petitions range from $60,000 at the low end to $150,000 at the high end, with a petition-weighted average of $101,157. That range reflects the mix of occupations the company sponsors, led by Senior Scientist (1 petitions at $108,000 avg), followed by Senior Project Manager and Senior Formulation Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Ascendia Pharmaceuticals, Inc is headquartered in North Brunswick, NJ under NAICS code 32541, and places H-1B workers across 1 state, most heavily in NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Ascendia Pharmaceuticals, Inc ranks. By H-1B petition volume, Ascendia Pharmaceuticals, Inc is #17,879 of 119,880 employers nationally and #1,461 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.